In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 105 for your search:
Drug:  zoledronic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GUS45, ZENITH, NCT00063609

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EUS97, US97, NCT00104104

3.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 120
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EIT04, NCT00219219

4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GGR01, NCT00219271

5.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EDE06, NCT00171964

6.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EDE15, NCT00172003

7.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GDE13, 2004-002831-14, NCT00333229

8.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EDE28, NCT00334139

9.

Phase: Phase IV
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GDE22, NCT00391690

10.

Phase: Phase IV
Type: Natural history/Epidemiology, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EAU22, NCT00434447

11.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EUS129, NCT00622505

12.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: IFM-04-01, NCT00733538

13.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: CZOL446ECN06T, NCT00762346

14.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: CZOL446ECN07, NCT00765687

15.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: AZABACHE: 2009-017440-13, NCT01087008

16.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446EUS147, NCT01129336

17.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: CZOL446GDE19, NCT00375752

18.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CZOL446ECN05, NCT00524849

19.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603010, UCLA-9911015

20.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000067052, NOVARTIS-4244603011, NCT00003884

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603039

22.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068781, U10CA031946, CALGB-79809, NCI-P01-0184, NCT00022087

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000069274, U10CA021115, E-E1A00, E1A00, NCT00033332

24.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 to 50
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CPMC-IRB-14069, NCI-G02-2127, NOVARTIS-CPMC-IRB-14069, NCT00049452

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SHEFF-AZURE, EU-20315, ISRCTN79831382, BIG-1-04, NCT00072020
1     
New Search